References for: association

Full identifier: http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T18:11:57.454Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
bortezomib for injection is a proteasome inhibitor indicated for treatment of patients with multiple myeloma 1 1 treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy 1 2 bortezomib for injection is indicated for the treatment of patients with multiple myeloma bortezomib for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy
Leoni Bücken
2021-06-27T18:11:57.454Z